iTonic (ITOC) vs Nuwellis (NUWE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
iTonic is the larger company by market cap ($11.6 million vs $1.8 million), about 6.3 times the size. Nuwellis converts more of its revenue into profit, with a net margin of -211.9% versus -974.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ITOC | NUWE |
|---|---|---|
| Share price | $1.59 | $3.41 |
| Market cap | $11.63M | $1.84M |
| 1-day change | +6.00% | -10.50% |
| YTD return | -76.40% | — |
| 1-year return | -81.96% | — |
| P/E ratio (TTM) | — | 0.00 |
| EPS (TTM) | $-4.22 | $3,609.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $523.03K | $8.27M |
| Revenue growth (YoY) | +16.70% | -5.38% |
| Net income (latest FY) | $-5.10M | $-17.52M |
| Gross margin | 62.59% | 61.96% |
| Operating margin | -991.71% | -134.29% |
| Net margin | -974.68% | -211.86% |
| 52-week high | $18.40 | $1,556.10 |
| 52-week low | $1.40 | $2.52 |
| Distance from 52-week high | -91.36% | -99.78% |
| Average volume | 42.84K | 829.19K |
| Shares outstanding | 6.84M | 540.91K |
| Employees | 7 | 38 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- iTonic is about 6.3 times larger than Nuwellis by market value ($11.63M vs $1.84M).
- Nuwellis is more profitable, keeping -211.9 cents of every revenue dollar as net income versus -974.7 cents for iTonic.
- iTonic grew revenue faster in its latest fiscal year (+16.70% vs -5.38%).
About iTonic
ITOC stock →iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 7 employees
About Nuwellis
NUWE stock →Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 38 employees
ITOC vs NUWE FAQ
Which is bigger, iTonic or Nuwellis?
iTonic (ITOC) is larger, with a market capitalization of $11.63M compared with $1.84M for Nuwellis (NUWE).
Are iTonic and Nuwellis in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.